Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Retroviral Agent”

302 trials

Showing 20 of 302 results

Testing effectiveness (Phase 2)Study completedNCT00002235
What this trial is testing

A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 6
Early research (Phase 1)UnknownNCT00002449
What this trial is testing

Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy

Who this might be right for
HIV Infections
Chiron Corporation 212
Early research (Phase 1)Study completedNCT00069498
What this trial is testing

Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 14
Testing effectiveness (Phase 2)Study completedNCT00002171
What this trial is testing

Viracept in HIV-Positive Women

Who this might be right for
HIV Infections
Agouron Pharmaceuticals
Not applicableStudy completedNCT00164762
What this trial is testing

Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers

Who this might be right for
HIV Infections
Centers for Disease Control and Prevention 126
Testing effectiveness (Phase 2)Looking for participantsNCT04648046
What this trial is testing

CAR-T Cells for HIV Infection

Who this might be right for
HIV Infections
Steven Deeks 18
Not applicableStudy completedNCT00000923
What this trial is testing

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 110
Testing effectiveness (Phase 2)Study completedNCT00002413
What this trial is testing

MKC-442 in HIV-Positive Patients

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT03762382
What this trial is testing

Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal Ring

Who this might be right for
HIVContraceptionPrevention+1 more
CONRAD 50
Not applicableStudy completedNCT00006444
What this trial is testing

The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women

Who this might be right for
HIV InfectionsPapilloma
National Institute of Allergy and Infectious Diseases (NIAID) 160
Early research (Phase 1)Study completedNCT00001133
What this trial is testing

Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT00002398
What this trial is testing

Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations

Who this might be right for
HIV Infections
Gilead Sciences
Early research (Phase 1)Study completedNCT00000865
What this trial is testing

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 32
Not applicableStudy completedNCT00001119
What this trial is testing

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 288
Not applicableStudy completedNCT00014937
What this trial is testing

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Large-scale testing (Phase 3)Study completedNCT00002429
What this trial is testing

Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

Who this might be right for
HIV Infections
Bristol-Myers Squibb 500
Post-approval studies (Phase 4)Study completedNCT00059384
What this trial is testing

Alternative Dosing Strategy for Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 66
Not applicableStudy completedNCT00002375
What this trial is testing

Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 24
Testing effectiveness (Phase 2)Study completedNCT00002412
What this trial is testing

MKC-442 in Combination With Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Post-approval studies (Phase 4)UnknownNCT00011895
What this trial is testing

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
GlaxoSmithKline 400
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation